These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8784866)

  • 1. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
    Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
    Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
    Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
    Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
    Wafelman AR; Hoefnagel CA; Beijnen JH
    Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
    Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
    J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
    Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
    Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid radiochemical purity testing for [131I]m-iodobenzylguanidine.
    Hung JC; Wilson ME
    Nucl Med Biol; 1995 Feb; 22(2):227-9. PubMed ID: 7767317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updating the procedure for metaiodobenzylguanidine labelling with iodine radioisotopes employed in industrial production.
    Franceschini R; Mosca R; Bonino C
    J Nucl Biol Med (1991); 1991; 35(4):183-5. PubMed ID: 1823814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiochemical purity and in vitro stability of commercial hippurans.
    Hammermaier A; Reich E; Bögl W
    J Nucl Med; 1986 Jun; 27(6):850-4. PubMed ID: 3712098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intravenous saline infusion compromise the stability of [123I] meta-iodobenzylguanidine?
    Martínez T; Chivato T; Roldán M; Miñana E
    Nucl Med Commun; 2014 Jun; 35(6):683-5. PubMed ID: 24637441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
    Howard JP; Maris JM; Kersun LS; Huberty JP; Cheng SC; Hawkins RA; Matthay KK
    Pediatr Blood Cancer; 2005 Mar; 44(3):232-9. PubMed ID: 15490487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine.
    Mairs RJ; Gaze MN; Watson DG; Skellern GG; Constable P; McKellar K; Owens J; Vaidyanathan G; Zalutsky MR
    Nucl Med Commun; 1994 Apr; 15(4):268-74. PubMed ID: 8072739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene therapy/targeted radiotherapy strategy for radiation cell kill by.
    Boyd M; Mairs RJ; Cunningham SH; Mairs SC; McCluskey A; Livingstone A; Stevenson K; Brown MM; Wilson L; Carlin S; Wheldon TE
    J Gene Med; 2001; 3(2):165-72. PubMed ID: 11318115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilisation of [131I]meta-iodobenzylguanidine at room temperature as organic extract in ethyl acetate/chloroform.
    Chattopadhyay S; Das MK; Sarkar BR; Prabhakar G; Mehra KS; Ramamoorthy N
    Appl Radiat Isot; 2001 Feb; 54(2):241-4. PubMed ID: 11200885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.